The Institute of Cancer Research, London, has expressed disappointment at the decision by NICE not to recommend abiraterone as a first-line treatment on the NHS for newly diagnosed, advanced prostate cancer.
Jun 26, 2020
0
3
Office visits for ongoing prescribing of skeletal muscle relaxant drugs tripled from 2005 to 2016, according to a new study from researchers in the Perelman School of Medicine at the University of Pennsylvania.
Jun 25, 2020
0
51
Cannabidiol, a type of medicinal cannabis, may reduce severe behavioural problems in children and adolescents with an intellectual disability a new study has found.
Jun 24, 2020
0
3
With over 2 million cases in the U.S. since the coronavirus pandemic began in late December, there are now many people who have recovered from COVID-19. At the same, there have been reports of people who continue to have ...
Jun 24, 2020
0
7
A new study by University of Chicago and University of California, Berkeley researchers suggests that women are being widely overmedicated—and suffering excess side effects—because drug dosages are calculated based on ...
Jun 24, 2020
0
17
(HealthDay)—The U.S. National Institutes of Heath announced Saturday that it was stopping a clinical trial of hydroxychloroquine, a drug long supported by President Donald Trump as a possible panacea for COVID-19.
Jun 22, 2020
0
2
Swiss pharmaceuticals giant Novartis has decided to halt a clinical trial of hydroxychloroquine as a treatment for COVID-19, citing problems in recruiting enough patients for the study of the controversial drug.
Jun 20, 2020
0
28
Clinical trials of a Russian coronavirus vaccine have started Wednesday, the Health Ministry said in a statement.
Jun 17, 2020
0
11
In research led by a University at Buffalo pediatric endocrinologist, a drug called golimumab showed that it preserved beta-cell function in children and young adults with newly diagnosed Type 1 diabetes, according to findings ...
Jun 16, 2020
0
4
Delta opioid receptors have a built-in mechanism for pain relief and can be precisely targeted with drug-delivering nanoparticles—making them a promising target for treating chronic inflammatory pain with fewer side effects, ...
Jun 15, 2020
0
553
